Aviso Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.25M Buy
5,214
+148
+3% +$151K 2.13% 11
2026
Q1
$4.66M Buy
5,066
+102
+2% +$103K 2.1% 10
2025
Q4
$5.34M Buy
4,964
+259
+6% +$248K 2.24% 8
2025
Q3
$3.59M Buy
4,705
+1,048
+29% +$780K 1.57% 17
2025
Q2
$2.85M Buy
3,657
+1,597
+78% +$1.24M 1.33% 17
2025
Q1
$1.7M Sell
2,060
-20
-1% -$16.6K 0.9% 29
2024
Q4
$1.61M Buy
2,080
+66
+3% +$54.6K 0.82% 32
2024
Q3
$1.78M Sell
2,014
-125
-6% -$112K 0.97% 26
2024
Q2
$1.94M Buy
2,139
+79
+4% +$63.2K 1.15% 16
2024
Q1
$1.6M Buy
2,060
+139
+7% +$98.9K 1.01% 26
2023
Q4
$1.12M Buy
+1,921
New +$1.12M 0.81% 32

Other funds holding LLY

Aviso Wealth Management's LLY Position: Q2 2026 in Review

Aviso Wealth Management increased its Eli Lilly (LLY) stake by 2.9% in Q2 2026, buying an estimated $151K and bringing the position to 5,214 shares worth $6.25M. The position accounts for 2.13% of the portfolio, ranked #11.

Aviso Wealth Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aviso Wealth Management held 5,214 shares of Eli Lilly worth $6.25M as of Q2 2026.
  • Aviso Wealth Management bought 148 Eli Lilly shares in Q2 2026, an estimated $151K.
  • Eli Lilly made up 2.13% of Aviso Wealth Management's portfolio in Q2 2026, its #11 holding.
  • Aviso Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aviso Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.